Fundraising Fox

Pellepharm

Menlo Park, US · Founded 2012 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

Pellepharm was founded in 2012 by Ervin Epstein and Jean Tang.

EE
Ervin EpsteinCo-founder
JT
Jean TangCo-founder
MD
Mark de SouzaExecutive

Board

KA
Katrin AndreassonBoard director

Investors · 2

Aisling CapitalNew York
EcoR1 CapitalSan Francisco

Reported raises · per SEC filings

Form D private placements

$19.6M disclosed across 8 rounds · 2014–2018

▶$7.5MraisedJul 2018 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sanuj Ravinddran, M.D.Executive Officer, Director, Promoter
  • Neil Kumar, Ph.D.Director
  • Frank McCormick, Ph.D.Director
  • Ervin Epstein, M.D.Director
  • Jean Y. Tang, M.D., Ph.D.Director
Offering amount
$7.5M
Amount sold
$7.5M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.2MraisedAug 2016 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Neil Kumar, PH.D.Director
  • Mark De Souza, Ph.D.Executive Officer, Director
  • Frank McCormick, Ph.D.Director
  • Ervin Epstein, M.D.Executive Officer, Director
  • Jean Tang, M.D., Ph.D.Director
Offering amount
$7.5M
Amount sold
$3.2M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$719.7KraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank McCormickDirector
  • Ervin EpsteinExecutive Officer, Director
  • Mark De SouzaExecutive Officer, Director
  • Neil KumarDirector
  • Jean TangDirector
Offering amount
$719.7K
Amount sold
$719.7K
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJul 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Katrin AndreassonDirector
  • Ervin EpsteinExecutive Officer, Director
  • Jean TangDirector
  • Mark de SouzaExecutive Officer
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$118.6KraisedMay 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ervin EpsteinExecutive Officer, Director
  • Jean TangDirector
  • Katrin AndreassonDirector
  • Mark de SouzaExecutive Officer
Offering amount
$118.6K
Amount sold
$118.6K
First sale
Jan 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedApr 2015 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ervin EpsteinExecutive Officer, Director
  • Jean TangDirector
  • Mark de SouzaExecutive Officer
  • Katrin AndreassonDirector
Offering amount
$1.8M
Amount sold
$1.8M
First sale
Mar 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedOct 2014 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ervin EpsteinExecutive Officer, Director
  • Katrin AndreassonDirector
  • Jean TangDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$476.2KraisedJul 2014 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ervin EpsteinExecutive Officer, Director
  • Jean TangDirector
  • Katrin AndreassonDirector
Offering amount
$476.2K
Amount sold
$476.2K
First sale
Jun 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Pellepharm?
Pellepharm was founded by Ervin Epstein, Jean Tang in 2012.
Who are Pellepharm's investors?
Pellepharm's investors include Aisling Capital, EcoR1 Capital.
How much funding has Pellepharm raised?
Pellepharm has disclosed $19.6M raised across 8 rounds.
Where is Pellepharm headquartered?
Pellepharm is headquartered in Menlo Park, US.